Clinical Trials Logo

Clinical Trial Summary

Suffering from dizzy spells and migraine headaches? Vestibular Migraine (VM), a newly recognized type of migraine that causes bouts of dizziness. University of California, Los Angeles (UCLA) and The Mayo Clinic is seeking people with VM to participate in a research study. The purpose of this study is to look at the natural history of VM and learn more about common symptoms. Investigators also want to learn the effects, both positive and negative, of the commonly used migraine drug, rizatriptan, when it is used for spells of dizziness in people with VM. Patients may be eligible to participate if: - Patients are between the ages of 18 & 65 - Patients have a history of vestibular migraine - Patients are able to maintain a vestibular symptom diary The study includes 3 visits with compensation. All participants must complete questionnaires on dizziness, headache symptoms, general health and well-being, mental health, and a questionnaire on patient's satisfaction with study medication.


Clinical Trial Description

The primary Specific Aim is to conduct the first successful controlled study of a treatment for Vestibular Migraine. The investigators hypothesize that rizatriptan will be superior to a look alike inactive capsule for: 1a. Reducing the severity and duration of vertigo attacks in patients with Vestibular Migraine, 1b. Reducing the severity of symptoms commonly associated with vertigo attacks in patients with Vestibular Migraine (e.g., nausea, vomiting, motion sensitivity, gait disturbance, headache, light and sound sensitivity), and 1c. Improving treatment satisfaction and health-related quality of life in patients with Vestibular Migraine, and that 1d. Rizatriptan will be well tolerated by patients with Vestibular Migraine. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02447991
Study type Interventional
Source University of California, Los Angeles
Contact
Status Completed
Phase Phase 2/Phase 3
Start date December 2014
Completion date July 31, 2020

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Recruiting NCT04417361 - Galcanezumab for Vestibular Migraine Phase 2
Enrolling by invitation NCT05396482 - Assesment of Hearing in Patients With Vestibular Migra
Completed NCT03979677 - Effects of Lifestyle Modification on Vestibular Migraine N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Not yet recruiting NCT05914207 - Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent N/A
Enrolling by invitation NCT06417684 - Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine Early Phase 1
Recruiting NCT04939922 - China Headache Registry Study
Recruiting NCT05472675 - Local Sensory Nerve Block in the Treatment of Vestibular Migraine N/A
Recruiting NCT05418218 - International Headache Registry Study
Suspended NCT04026516 - CAVA: Dizziness Trial N/A
Withdrawn NCT03578354 - 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine Phase 2
Completed NCT02350985 - Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine Phase 4
Completed NCT03417596 - Vestibular Rehabilitation in Patients With Vestibular Migraine N/A
Not yet recruiting NCT04664088 - Acupuncture for Prophylaxis of Vestibular Migraine N/A
Enrolling by invitation NCT06267924 - SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines N/A
Completed NCT05960786 - Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand N/A
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Not yet recruiting NCT05508139 - The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients
Completed NCT01669304 - Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness Phase 1